Daniel Mrak
8PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Sep 15, 2022
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls.Felix Kartnig, Daniel Mrak, Elisabeth Simader
|Sep 12, 2022
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial.Daniel Mrak, Daniela Sieghart, Elisabeth Simader
|Aug 17, 2022
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study.Daniel Mrak, Elisabeth Simader, Daniela Sieghart
|Mar 19, 2022
Response to SARS-CoV-2 vaccination in systemic autoimmune rheumatic disease depends on immunosuppressive regimen: a matched, prospective cohort study.Peter Mandl, Selma Tobudic, Helmut Haslacher
|Feb 25, 2022
Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trial.Michael Bonelli, Helga Radner, Andreas Kerschbaumer
|Jan 14, 2022
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial.Michael Bonelli, Daniel Mrak, Selma Tobudic
Pageof 2
Frequent Collaborators
8 joint publications
Daniel Aletaha
6 joint publications
Michael Bonelli
6 joint publications
Peter Mandl
5 joint publications
Helmuth Haslacher
5 joint publications
Leonhard X Heinz
5 joint publications
Elisabeth Simader
5 joint publications
Thomas Perkmann
3 joint publications
Stephan Blüml
3 joint publications
Andreas Kerschbaumer
2 joint publications
Felix Kartnig
